Zhou, J., An, G., Liu, Y., Yan, W., Du, C., Deng, S., Sui, W., Xu, Y., Qiu, L. (2025). In-class transition from bortezomib to ixazomib-based regimens in transplant-ineligible patients with newly diagnosed multiple myeloma: A retrospective, observational, real-world study conducted in China. Blood. https://doi.org/10.1182/blood-2025-7550